363 related articles for article (PubMed ID: 34336688)
1. Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study.
Zhang L; Wu X; Zhou J; Zhu M; Yu H; Zhang Y; Zhao Y; Han Z; Guo Y; Guan X; Wang X; Xu H; Sun L; Zhang J; Zhuang M; Xie L; Yu S; Chen P; Feng J
Front Oncol; 2021; 11():699323. PubMed ID: 34336688
[TBL] [Abstract][Full Text] [Related]
2. Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis.
Liu J; Sun X; Du Q; Yao J; Dai M; Cheng Q; Xu H; Li Y; Liu X; Zhang M; Zhou Y; Yang Y
Breast Cancer (Dove Med Press); 2022; 14():491-504. PubMed ID: 36575687
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study.
Yin S; Chi Y; Du Y; Wang J; Shan C; Yi W; Shang M; Man X; Tan Q; Li H
Cancer Med; 2023 Feb; 12(3):2333-2344. PubMed ID: 35894763
[TBL] [Abstract][Full Text] [Related]
4. Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study.
Li Y; Qiu Y; Li H; Luo T; Li W; Wang H; Shao B; Wang B; Ge R
Front Oncol; 2021; 11():664429. PubMed ID: 33996589
[TBL] [Abstract][Full Text] [Related]
5. Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis.
Lin Y; Lin M; Zhang J; Wang B; Tao Z; Du Y; Zhang S; Cao J; Wang L; Hu X
Cancer Res Treat; 2020 Oct; 52(4):1059-1066. PubMed ID: 32340083
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of trastuzumab and albumin-bound paclitaxel with or without pyrotinib as neoadjuvant therapy for HER2-positive breast cancer: a prospective observational cohort study.
Wang Y; Xu Y; Liu X; Li C; Wang J; Zhang X; Shao B; Zhang J
Gland Surg; 2024 May; 13(5):654-662. PubMed ID: 38845840
[TBL] [Abstract][Full Text] [Related]
7. Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study.
You S; Sang D; Xu F; Luo T; Yuan P; Xie Y; Wang B
Ther Adv Med Oncol; 2023; 15():17588359231217972. PubMed ID: 38145113
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice].
Song GH; Li HP; DI LJ; Yan Y; Jiang HF; Xu L; Wan DG; Li Y; Wang MP; Xiao Y; Zhang RY; Ran R; Wang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):254-260. PubMed ID: 32306007
[TBL] [Abstract][Full Text] [Related]
9. Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases.
Ma X; Li Y; Li L; Gao C; Liu D; Li H; Zhao Z; Zhao B
Ann Med; 2022 Dec; 54(1):3085-3095. PubMed ID: 36331291
[TBL] [Abstract][Full Text] [Related]
10. Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer.
Sun Y; Chen B; Li J; Peng L; Li S; Yu X; Li L
Cancer Manag Res; 2021; 13():7165-7174. PubMed ID: 34548820
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.
Huang J; Sun S; Tan Q; Zheng F; Zhou D; Man X; Hu Y; Li W; Song L; Zhang B; Xu L; Wang X; Xie X; Li H
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38729821
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study.
Li C; Bian X; Liu Z; Wang X; Song X; Zhao W; Liu Y; Yu Z
Cancer Med; 2021 Dec; 10(23):8352-8364. PubMed ID: 34672424
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China.
Liu X; Zhang P; Li C; Song X; Liu Z; Shao W; Li S; Wang X; Yu Z
Front Oncol; 2023; 13():1136380. PubMed ID: 37404769
[TBL] [Abstract][Full Text] [Related]
14. Pyrotinib combining with radiotherapy on breast cancer with brain metastasis.
Ma X; Li Y; Zhao Z; Li L; Gao C; Liu D; Li B; Zhao B
Exp Biol Med (Maywood); 2023 Jan; 248(2):106-116. PubMed ID: 36533572
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study.
Zhang X; Li Z; Han L; Lv Z; Teng Y; Cui X; Zhou C; Wu H; Fang W; Xu L; Zhao S; Song C; Zheng Y; Gao T; Li M
Onco Targets Ther; 2022; 15():1067-1078. PubMed ID: 36199295
[TBL] [Abstract][Full Text] [Related]
16. Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.
Li Y; Tong Z; Wu X; Ouyang Q; Cai L; Li W; Yu Z; Han Z; Wang X; Li M; Wang H; Li L; Yang J; Niu Z; Wang Q; Xu B
Int J Cancer; 2023 Nov; 153(10):1809-1818. PubMed ID: 37543965
[TBL] [Abstract][Full Text] [Related]
17. Pyrotinib versus trastuzumab emtansine for HER2-positive metastatic breast cancer after previous trastuzumab and lapatinib treatment: a real-world study.
Li F; Xu F; Li J; Wang T; Bian L; Zhang S; Jiang Z
Ann Transl Med; 2021 Jan; 9(2):103. PubMed ID: 33569405
[TBL] [Abstract][Full Text] [Related]
18. Pyrotinib Plus Vinorelbine
Xie Y; Li Y; Ting L; Sang D; Yuan P; Li W; Li H; Ge R; Wang B
Front Oncol; 2021; 11():699333. PubMed ID: 34422652
[TBL] [Abstract][Full Text] [Related]
19. Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer.
Yin Y; Yang H; Liu Z; Tan J; Zhu C; Chen M; Zhou R; Wang L; Qian J
Cancer Manag Res; 2020; 12():13479-13487. PubMed ID: 33408520
[TBL] [Abstract][Full Text] [Related]
20. Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study.
Zhang Q; He P; Tian T; Yan X; Huang J; Zhang Z; Zheng H; Zhong X; Luo T
Front Pharmacol; 2023; 14():1100556. PubMed ID: 37025489
[No Abstract] [Full Text] [Related]
[Next] [New Search]